Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

ClinicalTrials.gov ID: NCT00939094

Public ClinicalTrials.gov record NCT00939094. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIa, Double-Blind, Randomised, Parallel-Group, Multi-Centre Study to Evaluate the Analgesic Efficacy of 28 Days Oral Administration of AZD2066 Compared to Placebo in Peripheral Neuropathic Pain Patients With Mechanical Hypersensitivity

Study identification

NCT ID
NCT00939094
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
87 participants

Conditions and interventions

Interventions

  • AZD2066 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2009
Primary completion
Oct 31, 2010
Completion
Oct 31, 2010
Last update posted
Sep 26, 2012

2009 – 2010

United States locations

U.S. sites
38
U.S. states
17
U.S. cities
38
Facility City State ZIP Site status
Research Site Tucson Arizona
Research Site Los Angeles California
Research Site Sacramento California
Research Site San Francisco California
Research Site Walnut Creek California
Research Site Boulder Colorado
Research Site Atlantis Florida
Research Site Aventura Florida
Research Site Clearwater Florida
Research Site Fort Myers Florida
Research Site Orlando Florida
Research Site Palm Beach Gardens Florida
Research Site Sarasota Florida
Research Site St. Petersburg Florida
Research Site Sunrise Florida
Research Site Canton Georgia
Research Site Marietta Georgia
Research Site Evansville Indiana
Research Site New Orleans Louisiana
Research Site Brockton Massachusetts
Research Site Bingham Farms Michigan
Research Site Las Vegas Nevada
Research Site Reno Nevada
Research Site Lumberton New Jersey
Research Site Willingboro New Jersey
Research Site Albuquerque New Mexico
Research Site Jacksonville North Carolina
Research Site Winston-Salem North Carolina
Research Site Kettering Ohio
Research Site Portland Oregon
Research Site Bridgeville Pennsylvania
Research Site Philadelphia Pennsylvania
Research Site Austin Texas
Research Site Dallas Texas
Research Site Irving Texas
Research Site Lexington Texas
Research Site Longview Texas
Research Site San Antonio Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00939094, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 26, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00939094 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →